AstraZeneca PLC is 43.8x more valuable than Spyre Therapeutics, Inc. by market capitalization ($286.27 B vs $6.53 B). Every figure below comes from audited SEC filings and refreshed market data.
| Metric | SYRE | AZN |
|---|---|---|
| Market cap | $6.53 B | $286.27 B |
| US-listed rank | #1200 | #45 |
| Revenue (latest FY) | $0.00 | - |
| Net income (latest FY) | -$155.20M | - |
| SEC filings | 762 | 1,004 |
AstraZeneca PLC is 43.8x more valuable than Spyre Therapeutics, Inc. by market capitalization ($286.27 B vs $6.53 B).
Full pages: Spyre Therapeutics, Inc. and AstraZeneca PLC, or browse the full rankings.